A fruitful and dynamic technology transfer is indispensable to make results from science and research usable for patients. Charité BIH Innovation offers a wide range of service units and funding instruments for the implementation of innovative ideas. This innovation ecosystem is now complemented by the new Idea Office – the contact point for…
After a three-day pitch event in September, an expert jury selected fourteen outstanding translational projects for funding by the BIH / the NeuroCure cluster of excellence. The teams at SPARK-BIH and NeuroCure welcomed the new SPARKees during an onboarding event and are excited to support the translation of their medical innovation from bench to…
After two years of intensive renovation work, the new location of Charité BIH Innovation (CBI) - the joint technology transfer of Charité and BIH - has opened on October 12. Covering a total of 2,500 m2 spread over four floors, the modern, expanded new-work space (Am Zirkus/ Bertolt-Brecht-Platz 3, 10117 Berlin) unites a wide variety of development…
In May 2022, after more than 15 years of intensive research activity at Charité Universitätsmedizin Berlin, Dr. Wallach joined the team of the in-house technology transfer office Charité BIH Innovation (CBI) as technology manager. Now, due to his great ambition and potential for detecting, managing and protecting promising scientific discoveries,…
The newly formed research collaboration between Pantherna Therapeutics and clinical researchers at Charité – Universitätsmedizin Berlin aims at investigating the potential of therapeutic mRNA in autoimmune diseases. Charité BIH Innovation offers consultation and support during the translational process.
The BIH DHA spin-off AIgnostics successfully closes a €14 million Series A round to enter additional markets.
MyoPax, a new spin-off of the Max Delbrück Center and Charité, is receiving a €1.3 million loan to jump-start its business development. The start-up uses its innovative stem cell technology to create regenerative therapies for previously incurable muscle diseases. The BIH has provided support and guidance to the spin-off through SPARK-BIH, a…
